AT 1 Receptor Blockade and Atherosclerosis
- 4 April 2000
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (13) , 1496-1497
- https://doi.org/10.1161/01.cir.101.13.1496
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- An endothelial receptor for oxidized low-density lipoproteinNature, 1997
- Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.Journal of Clinical Investigation, 1996
- A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.Journal of Clinical Investigation, 1995
- Transforming growth factor 1 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: effects of inhibition of the renin-angiotensin systemCardiovascular Research, 1994
- Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits.Journal of Clinical Investigation, 1993
- Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractionsThe Lancet, 1992
- Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.Hypertension, 1990
- Felodipine Extended-Release Tablets Once Daily Are Equivalent to Plain Tablets Twice Daily in Treating HypertensionJournal of Cardiovascular Pharmacology, 1990
- Effects of Captopril on Atherosclerosis in Cynomolgus MonkeysJournal of Cardiovascular Pharmacology, 1990